Donald R Gehlert Selected Research

Donald R Gehlert Research Topics

Disease

5	Alcoholism (Alcohol Abuse) 04/2011 - 03/2007
2	Body Weight (Weight, Body) 01/2014 - 02/2006
2	Weight Gain 01/2014 - 02/2006
2	Obesity 05/2009 - 02/2006
2	Anxiety Disorders (Anxiety Disorder) 02/2005 - 04/2003
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Hyperglycemia 01/2014
1	Neurodevelopmental Disorders 12/2013
1	Mental Disorders (Mental Disorder) 12/2013
1	Schizophrenia (Dementia Praecox) 12/2013
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2013
1	Hyperinsulinism (Hyperinsulinemia) 06/2012
1	Nausea 04/2011
1	Vomiting 04/2011
1	Social Phobia 02/2010
1	Hyperthermia 01/2008
1	Hypertension (High Blood Pressure) 09/2006
1	Tachycardia (Tachyarrhythmias) 09/2006
1	Panic Disorder (Panic Attack) 09/2006
1	Tachypnea 09/2006
1	Mood Disorders (Mood Disorder) 04/2006
1	Pain (Aches) 04/2006
1	Seizures (Absence Seizure) 09/2005
1	Temporal Lobe Epilepsy 09/2005
1	Substance-Related Disorders (Drug Abuse) 11/2002
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2002

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 06/2012 - 03/2008
2	LY686017IBA 04/2011 - 02/2010
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 04/2011 - 03/2008
1	Opioid Receptors (Opioid Receptor)IBA 01/2023
1	GlucocorticoidsIBA 01/2014
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2014
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2014
1	Mifepristone (RU 486)FDA Link 01/2014
1	N- (5- (tert- butyl)- 3- (2- fluoro- 5- methylpyridin- 4- yl)- 2- methyl- 1H- indol- 7- yl)methanesulfonamideIBA 01/2014
1	Antipsychotic Agents (Antipsychotics)IBA 01/2014
1	Olanzapine (Zyprexa)FDA Link 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2014
1	methanesulfonamideIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2013
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 12/2013
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 12/2013
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 09/2010
1	Neurokinin-1 Receptor AntagonistsIBA 02/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2009
1	NeuropeptidesIBA 11/2009
1	Nociceptin ReceptorIBA 11/2009
1	NociceptinIBA 11/2009
1	melanin-concentrating hormone receptorIBA 05/2009
1	Neuropeptide YIBA 01/2008
1	CRF receptor type 1IBA 03/2007
1	pyridazineIBA 03/2007
1	Dimenhydrinate (DMH)FDA LinkGeneric 09/2006
1	AllylglycineIBA 09/2006
1	Yohimbine (Yocon)IBA 09/2006
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2006
1	Sodium Lactate FDA LinkGeneric 09/2006
1	gamma-Aminobutyric Acid (GABA)IBA 09/2006
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2006
1	Peptides (Polypeptides)IBA 04/2006
1	sibutramine (Meridia)FDA Link 02/2006
1	Biogenic Amines (Biogenic Amine)IBA 02/2006
1	Serotonin (5 Hydroxytryptamine)IBA 02/2006
1	BIIE 0246IBA 09/2005
1	Kainic Acid (Kainate)IBA 09/2005
1	UrocortinsIBA 02/2005
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2002
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 11/2002
1	Methylphenidate (Ritalin)FDA LinkGeneric 11/2002
1	CatecholaminesIBA 11/2002
1	Therapeutic UsesIBA 11/2002
1	Dopamine (Intropin)FDA LinkGeneric 11/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 11/2002
1	Drug Therapy (Chemotherapy) 04/2011
1	Injections 09/2005